A cohort analysis of 56 patients with dilated cardiomyopathy (DCM) showed that HF patients had higher percentages of CD19+ B cells and actively replicating CD19+ B cell in peripheral blood than healthy volunteers. This evidence concerns the gene CD19 and familial dilated cardiomyopathy.